Objective: To identify differences in amount and distribution of fat and lean soft tissue in a cross-sectional study of subjects with and without type 2 diabetes and to determine whether any differences are affected by race/ethnicity or sex. Design and methods: Overweight and obese (body mass index, BMIX25 kg m À2 ) Black, White and Hispanic men (490) and women (825) with type 2 diabetes ((mean±s.d.) age 58.5±6.6; BMI 35.3±5.3) who had a baseline dual energy X-ray absorptiometry whole-body scan at the time of enrollment in the Look AHEAD clinical trial, and 242 healthy controls, 91 males and 151 females (age 55.3±8.6 years, BMI 30.7±4.2 kg m À2 ) who were participating in unrelated research and were scanned on the same densitometers. Results: Adjusted for gender, age, race, clinical site and body size, total fat mass was smaller in persons with type 2 diabetes than in controls (À1.4 ± 0.3 (s.e.); 34.5 vs 35.8 kg, Po0.001) while trunk fat was larger (1.3 ± 0.2 (s.e.); 19.9 vs 18.6 kg, Po0.001) and leg fat was smaller (À1.5±0.2 (s.e.); 10.7 vs 12.3 kg, Po0.001). The arms of subjects with type 2 diabetes did not have significantly less fat compared to controls. Adjusted trunk lean mass was larger in type 2 diabetes by 0.6 kg (28.4 vs 27.8 kg, Po0.001) while leg lean was smaller by 0.5 kg (18.1 vs 18.6 kg, Po0.001). Conclusions: Type 2 diabetes is associated with less total fat, leg fat and leg lean mass and more truncal fat and lean mass than controls. The physiological processes producing these deviations in tissue distribution and their metabolic significance warrant further investigation.
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Alternatively, body composition may be altered by the disease process. In either case, a clear understanding of the nature and degree of the alterations is necessary to provide a basis for further investigation into the underlying physiological processes.
Several studies have used dual energy X-ray absorptiometry (DXA) to study fatness and fat distribution in persons with type 2 diabetes mellitus (T2DM) compared with healthy controls. The results have not been entirely consistent. Svendsen and Hassager 5 reported more total body fat (TBF)
in premenopausal but not in postmenopausal women with type 2 diabetes compared with healthy controls. Maiolo et al. 6 , in a study of body composition and pulmonary function in matched type 2 diabetes and control groups of women reported more lean mass and nonsignificantly less fat mass in type 2 diabetes. Poynten et al. 7 observed no difference in percentage TBF between weight and body mass index (BMI)-matched controls and subjects with type 2 diabetes. Studies that report fat as a proportion of total body weight often find subjects with type 2 diabetes to have higher percentage of fat. 8 Many, but not all, studies have observed larger abdominal fat deposits in type 2 diabetes. 6, 9 Stoney et al. 10 found no differences in overall fatness between matched groups of postmenopausal women but observed less lower body (leg) fat in the group with type 2 diabetes. Tafeit et al. 11 made subcutaneous adipose tissue measures at sites distributed over the entire body of subjects with type 2 diabetes and controls using an optical device (lipometer). They documented more upper trunk and less leg subcutaneous adipose tissue in women with type 2 diabetes than in control women. Most of these studies were relatively small casecontrol samples with limited power. Although larger fat masses are generally associated with greater risk, it has been proposed that greater amounts of leg and thigh fat may be associated with less cardiovascular disease risk or may be protective against cardiovascular disease.
10,12-14 Recently, Snijder et al. 15 found smaller amounts of leg fat to have independent positive associations with elevated fasting and 2-h glucose levels in a sample of normal glucose-tolerant, impaired glucose-tolerant and diabetic subjects. In another study, Snijder et al. 16 reported positive associations of leg fat mass with less peripheral arterial stiffness. Many of the published reports of alterations in body composition associated with diabetes were limited in the ethnic composition of the sample, used only anthropometric measures of body composition, were studied in an elderly population, had low power to detect small differences and interactions or neglect to report them. There are also unanswered questions about the amount and distribution of lean soft tissue in relation to disease status and whether arm fat or arm lean mass as well as leg fat or leg lean mass may have independent associations with type 2 diabetes.
A substudy of the Look AHEAD clinical trial provided an opportunity to investigate these questions using DXA in a large sample of well-characterized patients with type 2 diabetes and to compare amounts and distributions of body tissue with a sample of healthy control subjects. The objectives of the present analysis of this substudy group were to identify differences in total amount and distribution of tissues in subjects with and without type 2 diabetes after controlling for potential confounders, and to determine whether any differences observed are modified by race/ ethnicity or sex.
Research design and methods
A subset of the subjects enrolling in the Look AHEAD study, an NIH-sponsored multi-center randomized clinical trial of the effects of intentional weight loss interventions on the incidence of major cardiovascular events in overweight and obese persons diagnosed with T2DM, 17 underwent baseline whole-body DXA scans at one of five clinical study sites (Baton Rouge, Boston, Houston, Los Angeles, Seattle; total N ¼ 1375). Enrollment criteria included age (X45 years), overweight and obese (BMI X25 kg m À2 ) and diagnosed T2DM. A complete description of enrollment criteria is found elsewhere.
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All sites used Hologic QDR4500A densitometers except for Boston (Hologic Delphi A). Any software upgrades during the study were approved and monitored by the central DXA reading center (Prevention Sciences Group, University of California at San Francisco). Participant scans were centrally monitored for quality. A set of traveling phantoms (spine, hip, linearity and whole body) was scanned on all densitometers to assess differences across machines. A quality control program was in place that included regular scans of spine and whole-body phantoms and air scans at all sites. The records of these QC scans were reviewed and monitored by the DXA reading center. The regions of interest used in this study (leg, trunk and arm) are those provided by the software default, adjusted by the DXA operator in those cases where the software obviously failed to achieve the intended anatomical demarcations. The principles of the DXA methodology provide a two-compartment measurement of fat and fat-free mass on the molecular level, and the fat-free component can be subdivided into bone mineral and soft tissue. The term lean tissue as used in our text and tables refers to lean soft tissue.
In addition to the subjects with type 2 diabetes, data were available from a sample of healthy men and women, participating in unrelated research at two of the five clinical sites (Baton Rouge and Los Angeles) who were scanned on the same densitometers as used for the Look AHEAD subjects (total N ¼ 254). Control subjects were selected to meet the same age and BMI minimum values as Look AHEAD subjects.
Biographical, medical (length of time since diagnosis) and body composition data for Look AHEAD study subjects were obtained from the coordinating center for the Look AHEAD study (Wake Forest University Baptist Medical Center). Race/ ethnicity was classified as Hispanic, non-Hispanic White (White) and non-Hispanic Black (Black) according to selfreport. Our study sample was restricted to Black, White and Hispanic race/ethnicity groups because adequate numbers of other race groups were not available. Fifty-seven Look AHEAD subjects and 12 control subjects were excluded because of technical or positioning errors during scan acquisition.
Statistical analysis
General linear models were used to evaluate the independent associations of diabetes status with whole-body fat and lean tissue, and fat/lean tissue distribution in the trunk, leg and arm regions. A dummy variable for clinical site was included in all the models. Variables entered in the models along with diabetes status and site included weight (in whole-body analyses) or whole-body fat/lean mass (in models of fat/lean distribution), height, age, gender and race/ethnicity group. All outcome variables were tested for normality, and no transformations were found to be necessary. Correlations between covariates were checked to be sure that all variables could be appropriately adjusted simultaneously. Potential nonlinear trends between all continuous covariates and Altered body composition in type 2 diabetes S Heshka et al outcome variables were assessed and none were found. All two-and three-way interaction terms of categorical variables, and all two-way interactions with continuous variables were tested for significance and were removed if found nonsignificant. Residuals were checked for normality and homoscedasticity.
Analyses were carried out using SAS v 9.1 (Cary, NC, USA). Po0.05 was set as the significance level. Multiple comparisons were Tukey-Kramer adjusted.
Results

Subject characteristics
Characteristics of subjects in this study are listed in Table 1 (men) and Table 2 (women). Mean duration since diagnosis of diabetes in the Look AHEAD participants was 6.7 ± 6.5 years. Despite the same BMI and age-eligibility cutoff values for the control and T2DM samples, the control group was younger, weighed less and was of smaller body habitus as assessed by BMI (Po0.005), although the range of data points was similar (type 2 diabetes, age 45-76 years, BMI 25-54, weight 58-160 kg; controls, age 45-75 years, BMI 25-49, weight 58-142 kg). Because of these differences in mean values, we do not present unadjusted comparisons of any body composition compartments.
Since our analyses compare fatness adjusted for weight between subjects with type 2 diabetes and controls, it was important to verify that a similar relationship existed between weight and fat mass in the two groups. Scatter plots of fat mass vs weight showed that over the observed range, the relationships were linear in both groups and that the regression coefficients of fat mass on weight in the two groups were not different (P ¼ 0.24) (Figure 1 ).
Total body fat and lean mass in diabetic and control subjects In a multiple regression model, TBF mass was independently associated with diabetes status as well as with weight, gender, height, race/ethnicity and age (all Po0.001). After adjustment for covariates, persons with type 2 diabetes had 1.36 kg (s.e. 0.28) less fat mass than controls (mean 34.5 vs 35.8 kg, Po0.001) ( Table 3 ). There was no interaction of diabetes status with race/ethnicity or gender indicating that the Abbreviations: BMC, bone mineral content; BMI, body mass index. Because control subjects weigh less and are of lower BMI than corresponding type 2 diabetes subjects (both Po0.005), we do not present statistical comparisons of unadjusted body compartment. The finding of less total fat mass in diabetic subjects was confirmed by an analysis with whole-body lean mass as the dependent variable. Adjusted for race, gender, age, height, weight, clinical site and interactions, as in the model for fat mass, subjects with diabetes had 1.3 kg (s.e. 0.28) more lean body mass than healthy controls (Po0.001) ( Table 3) .
Trunk fat and lean mass in diabetic and control subjects Although subjects with type 2 diabetes had relatively less fat mass than controls, a second question was how fat mass was distributed along the truncal/peripheral dimension as measured by DXA. Regression models showed independent associations of trunk fat adjusted for total fat with diabetes status, gender, race/ethnicity (all Po0.001), height (P ¼ 0.02), age (P ¼ 0.08) and clinical site. After adjustment for these other variables, the diabetes group had a mean of 1.28 kg (s.e. 0.16) more trunk fat than controls (19.9 vs 18.6 kg, Po0.001) ( Table 4 ). Trunk lean mass adjusted for total lean mass was greater in the diabetes group by 0.61 kg (28.4 vs 27.8 kg, Po0.001). Therefore, both fat and lean masses are relatively larger in the truncal region of subjects with type 2 diabetes compared to controls. There were no interactions with race/ethnicity or gender.
Leg and arm fat and lean mass in diabetic and control subjects Further analyses explored whether the larger amount of trunk fat observed in the diabetes subjects occurred at the expense of peripheral fat in general or whether it was specifically lower extremity fat that was depleted. In general, linear regression models leg fat was found to be independently and significantly related to diabetes status, gender, height, total fat mass and race (all Pp0.001) ( Table 4) . Subjects with diabetes had 1.5 kg (s.e. 0.16) less leg fat than controls (10.7 vs 12.3 kg, Po0.001). For arm fat, there was a gender by diabetes status interaction: women with type 2 diabetes had more arm fat than controls (4.7 vs 4.3 kg, Po0.001) while men did not differ from controls (4.1 vs 4.1 kg, P ¼ 0.99). These results indicate a relative depletion of fat in the legs of subjects with type 2 diabetes, which is not Whole-body bone mineral in diabetic and control subjects Regression models of whole-body bone mineral content found no association of type 2 diabetes with bone mineral content after adjustment for race, gender, height, weight (all Po0.001), age (P ¼ 0.03) and clinical site (Table 3 ). There were no significant interactions among variables.
Discussion
In this study, we observed a smaller fat mass (B1.4 kg) in subjects with type 2 diabetes compared to healthy controls after adjustment for weight, height, age, gender, race/ ethnicity and clinical site. This fat mass was distributed more centrally, with larger deposits in the trunk region and smaller deposits in the leg region. The arm region had marginally larger amounts of fat in women but did not differ from controls in men. The distribution of lean tissue in type 2 diabetes compared to controls followed a similar pattern to that of fat: more in the trunk region, less in the leg, except that the larger fat mass seen in the arm region of women with diabetes was not matched by more lean tissue in the arm (Figure 2 ). Models with fat as a dependent variable are adjusted for total fat mass; models with lean tissue-dependent variable are adjusted for total lean mass. Figure 2 Mean differences between fat and lean masses adjusted for covariates (gender, race, total fat or lean mass, height, age and two-and three-way interactions, if any) in leg, trunk and arm regions of type 2 diabetes mellitus and control subjects, with control values as the zero reference. ArmFat_W and ArmFat_M is arm fat for women and men, respectively.
Altered body composition in type 2 diabetes S Heshka et al
Previous studies reported TBF to be either greater or not different in T2DM premenopausal women compared to controls (some studies matched for age, others for weight and BMI). [5] [6] [7] Studies that report fat as a proportion of total weight often find subjects with type 2 diabetes to have a higher proportion of body weight as fat. 8 In contrast, we found that after adjustment by regression for weight, height, race/ethnicity, sex and age, subjects with type 2 diabetes had less total fat mass and more lean mass than controls. Some of the inconsistencies in findings may be the result of low power to detect differences, of expressing fat mass as a percentage of body weight rather than using weight as a covariate and possibly also of not adjusting for other relevant variables such as age and height. It may be noted that in each of the within-race comparisons in our sample, the fat mass expressed as a percentage of weight was higher in the diabetes subjects than in controls (Tables 1 and 2 ). There are well-documented hazards in comparing groups using ratio measures such as fat mass divided by body weight.
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While a difference of 1.4 kg of total fat mass, given a mean total fat mass of 30-40 kg, is small, the direction of the difference is unexpected in that, other factors being equal, greater fatness is usually positively related to metabolic disturbances. 19 It appears that in this sample of diabetes subjects, an adverse pattern of fat distribution is more strongly associated with the disease than is the total amount of fat suggesting possible loss of, or failure to deposit and retain, beneficial fat depots. The finding of a larger amount of fat in the trunk region in type 2 diabetes (B1.3 kg) compared with controls is consistent with some but not all previous small studies 6, [9] [10] [11] and is generally supported by larger epidemiological studies. 8, 20 We find that this enlarged truncal adiposity extends across race/ethnicity and sex groupings in our sample. The relative contribution of subcutaneous and intra-abdominal deposits to the differences in truncal fat seen in this study cannot be determined from DXA measures; however, studies using other body composition measures such as computed tomography have investigated the distinct roles of subcutaneous and intra-abdominal compartments of truncal fat and their independent associations with metabolic variables. 1, 2 Differences in metabolic activity (lipolysis, adipokines) in the subcutaneous and intra-abdominal compartments have been reported but the roles of other, more specific, adipose subcompartments (omental, mesenteric, pelvic, epicardial, deep vs superficial subcutaneous, inter-and intramuscular) remain to be investigated and characterized. In addition to having more of their fat in the truncal region, subjects with type 2 diabetes had less leg fat (B1.5 kg) and this finding also held across race/ethnicity and sex groups in our sample. A graded difference in the amount of leg fat has also been observed in impaired glucose-tolerant and diabetic subjects compared to healthy controls. 21 Recently, the notion that fat deposits in the femoral/gluteal region may be protective for the development of diabetes and risk for cardiovascular disease has been advanced with studies showing positive associations of these fat deposits with better glucose metabolism 15 and lower arterial stiffness. 16, 22 Although leg fat may be subdivided into subcutaneous, intermuscular and intramuscular fat, the subcutaneous deposit, which is the major component, is likely to be responsible for any beneficial association. In the Health ABC Study, leg fat has been subdivided into different fat deposits and related to metabolic disturbances, confirming the importance of subcutaneous leg fat for the beneficial associations. 23 The arm regions of subjects with type 2 diabetes did not have less fat compared to controls suggesting that the fat distribution differences are mainly trunk vs leg rather than central vs peripheral or upper vs lower body. The metabolic significance of a reduced capacity to deposit or conserve leg fat, or an enhanced capacity to store fat centrally in type 2 diabetes remains to be elucidated. It has been proposed that subcutaneous abdominal fat contributes to higher nonesterified fatty acid levels whereas subcutaneous fat on the thigh may act as a metabolic sink for these circulating fatty acids, or that regional differences in the secretion of adipokines and inflammatory/fibrinolytic proteins may be accounting for the different associations of these fat depots with glucose and lipid levels and with arterial stiffness. 16, 21 Future studies might look at whether weight loss in subjects with type 2 diabetes tends to normalize fat distribution toward that of controls. An interesting observation is that the excess amount of truncal fat in type 2 diabetes compared to controls is mirrored by an excess of lean tissue of about one-third the size, and the deficit of fat in the legs has a corresponding deficit of lean tissue, again of about one-third or one-quarter the size of the fat deviations. These proportions of fat to lean tissue are approximately similar to those reported in studies of weight loss or gain. The significance of these regional excesses and deficits of lean tissue is not well established at present; however, they may have independent associations with metabolic variables. 15 Of the eight soft-tissue regression models reported here, there was only one statistical interaction of gender or race with diabetes status: women with type 2 diabetes had significantly more arm fat (0.4 kg) than controls whereas men did not differ. This suggests that the association of diabetes status with the pattern of altered fat and lean-tissue distribution reported here is relatively robust to gender and race/ethnicity differences.
Total bone mineral content was similar in those with and without diabetes after taking into account body size. Extensive data are available on diabetes and bone density at other skeletal sites, suggesting average or elevated bone density compared to those without diabetes after adjustment for body size. 24 However, there are few published studies on total bone density and type 2 diabetes. In the largest study published, Strotmeyer et al. 25 found higher total BMD with type 2 diabetes in older adults, including men and women, Black and White participants, after accounting for lean mass The principal strength of our study is the large, multiethnic sample of well-characterized subjects with type 2 diabetes, who were all studied using the same protocol and similar cross-calibrated instrumentation at multiple study sites. This permitted us to carry out powerful statistical tests for differences in fat content and distribution between T2DM and controls and to determine whether these differences were affected by sex and race/ethnicity. Our study also has certain limitations. The cross-sectional design makes it impossible to examine the time course of the development of the observed differences thus limiting us to speculation on causality. The controls were a convenience sample of nondiabetic subjects from other studies, the Hispanic control group was small and many measures that would have been useful in analyses (for example, waist circumference, smoking, physical activity) were not available. Look AHEAD is a clinical trial, and our subjects had a higher BMI, were better educated and were less likely to smoke than the persons with diabetes in the National Health and Nutrition Examination Surveys. Our analyses may not have been able to adjust completely for confounders, such as the larger weight and fat mass in diabetic subjects, different race/ ethnicity proportions and sex composition of groups, and for other unknown but correlated factors; thus, some of our findings could be due to residual confounding and not due to true associations. DXA measures are not able to discriminate many tissue subcompartments, which may be important to understanding the observed differences.
Conclusions
In multiple regression models adjusted for weight, height, age, sex and race/ethnicity, we found that subjects with type 2 diabetes had less fat mass and more lean mass than healthy controls. There were also differences in tissue distribution with an excess of fat and lean tissue in the truncal region and a deficit of fat and lean in the leg region in subjects with type 2 diabetes compared to controls. There was no deficit of fat in the arm region. The physiological processes producing these deviations in tissue distribution and their metabolic significance require further investigation.
